Learn More
Summary:Up to a third of autologous transplantation candidates fail to mobilize hematopoietic progenitors into the peripheral blood with chemotherapy and/or growth factor treatment, thus requiring(More)
4724 Background: Pts with International Germ Cell Cancer Collaborative Group (IGCCCG) "poor prognosis" disease achieve only a 41% 5-year progression-free survival (PFS) with standard chemotherapy.(More)